Literature DB >> 1373200

Identification of T-helper epitopes in the VP1 capsid protein of poliovirus.

M Kutubuddin1, J Simons, M Chow.   

Abstract

Poliovirus-specific T lymphocytes were isolated from virus-immunized mice of different H-2 haplotypes. Immunological characterization of this population indicates that the effector population involved in the observed poliovirus-specific proliferative response was that of CD4-positive T-helper cells. Proliferative responses also were induced within these T-lymphocyte populations upon stimulation with either purified VP1 capsid protein or VP1 synthetic peptides. By using these synthetic peptides, several T-helper epitopes were identified. Generally, proliferative responses were observed in three regions of VP1. Two regions spanning VP1 residues 86 to 120 and 201 to 241 were recognized by T lymphocytes from BALB/c (H-2d), C57BL/6 (H-2b), and C3H/HeJ (H-2k) backgrounds. Analyses using synthetic peptides of nonoverlapping sequences indicated that the region spanning residues 201 to 241 may contain several T epitopes and may account for the strong proliferative response observed. In addition, for two of the three haplotypes examined, T epitopes were observed within residues 7 to 24 of VP1. Additional epitopes which appeared to be restricted to specific H-2 backgrounds were identified. T epitopes within VP1 that are common between different strains of mice appeared to lie within previously identified neutralizing antigenic sites in poliovirus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373200      PMCID: PMC241064     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Myristoylation is important at multiple stages in poliovirus assembly.

Authors:  N Moscufo; J Simons; M Chow
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Antigenic structure of polioviruses of serotypes 1, 2 and 3.

Authors:  P D Minor; M Ferguson; D M Evans; J W Almond; J P Icenogle
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

3.  Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies.

Authors:  M Chow; R Yabrov; J Bittle; J Hogle; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Immune response to synthetic herpes simplex virus peptides: the feasibility of a synthetic vaccine.

Authors:  E Heber-Katz; B Dietzschold
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

5.  Three-dimensional structure of poliovirus serotype 1 neutralizing determinants.

Authors:  G S Page; A G Mosser; J M Hogle; D J Filman; R R Rueckert; M Chow
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

6.  Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme.

Authors:  S Demotz; H M Grey; E Appella; A Sette
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

7.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.

Authors:  D P Dialynas; Z S Quan; K A Wall; A Pierres; J Quintáns; M R Loken; M Pierres; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

8.  Antigen-induced proliferation assay for mouse T lymphocytes. Response to a monovalent antigen.

Authors:  S S Alkan
Journal:  Eur J Immunol       Date:  1978-02       Impact factor: 5.532

9.  A sequence pattern common to T cell epitopes.

Authors:  J B Rothbard; W R Taylor
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

10.  Repertoires of T cells directed against a large protein antigen, beta-galactosidase. II. Only certain T helper or T suppressor cells are relevant in particular regulatory interactions.

Authors:  U Krzych; A V Fowler; E E Sercarz
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

View more
  11 in total

1.  Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio.

Authors:  Rahnuma Wahid; Martin J Cannon; Marie Chow
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.

Authors:  Amir-Babak Sioofy-Khojine; Jussi Lehtonen; Noora Nurminen; Olli H Laitinen; Sami Oikarinen; Heini Huhtala; Outi Pakkanen; Tanja Ruokoranta; Minna M Hankaniemi; Jorma Toppari; Mari Vähä-Mäkilä; Jorma Ilonen; Riitta Veijola; Mikael Knip; Heikki Hyöty
Journal:  Diabetologia       Date:  2018-02-05       Impact factor: 10.122

3.  Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy.

Authors:  D R Kilpatrick; B Nottay; C F Yang; S J Yang; E Da Silva; S Peñaranda; M Pallansch; O Kew
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain.

Authors:  H Zhang; P Morgan-Capner; N Latif; Y A Pandolfino; W Fan; M J Dunn; L C Archard
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

5.  Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.

Authors:  I Callebaut; V Vonèche; A Mager; O Fumière; V Krchnak; M Merza; J Zavada; M Mammerickx; A Burny; D Portetelle
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

6.  Poliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions.

Authors:  M Kutubuddin; J Simons; M Chow
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

7.  A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model.

Authors:  H Zhang; N W Blake; X Ouyang; Y A Pandolfino; P Morgan-Capner; L C Archard
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans.

Authors:  J Simons; M Kutubuddin; M Chow
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis.

Authors:  D Finke; U G Brinckmann; V ter Meulen; U G Liebert
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  A dominant EV71-specific CD4+ T cell epitope is highly conserved among human enteroviruses.

Authors:  Ruicheng Wei; Chunfu Yang; Mei Zeng; Frances Terry; Kai Zhu; Chunhui Yang; Ralf Altmeyer; William Martin; Anne S De Groot; Qibin Leng
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.